Novo Nordisk A/S logo

Novo Nordisk A/S - Class B

2
OCSE:NOVO B (Denmark)   Class B
kr 881.30 (-0.79%) Mar 27
47.34
P/B:
36.87
Market Cap:
kr 3.93T ($ 568.74B)
Enterprise V:
kr 3.93T ($ 568.27B)
Volume:
2.54M
Avg Vol (2M):
3.03M
Also Trade In:
Volume:
2.54M
Avg Vol (2M):
3.03M
Market Cap kr M 3,932,386.86
Enterprise Value kr M 3,929,162.86
P/E(ttm) 47.34
PE Ratio without NRI 47.34
Forward PE Ratio 38.17
Price/Book 36.87
Price/Sales 17.05
Price/Free Cash Flow 56.69
Price/Owner Earnings 45.73
Payout Ratio % 0.38
Revenue (TTM) kr M 232,261.00
EPS (TTM) kr 18.61
Beneish M-Score -2.58
10-y EBITDA Growth Rate % 11.70
5-y EBITDA Growth Rate % 17.50
y-y EBITDA Growth Rate % 50.90
EV-to-EBIT 37.02
EV-to-EBITDA 34.00
PEG 2.71
Shares Outstanding M 4,462.03
Net Margin (%) 36.03
Operating Margin % 44.16
Pre-tax Margin (%) 45.07
Quick Ratio 0.64
Current Ratio 0.82
ROA % (ttm) 30.18
ROE % (ttm) 92.29
ROIC % (ttm) 30.03
Dividend Yield % 1.07
Altman Z-Score 13.55
Piotroski F-Score 8.00
Positive ROA Y
Positive CFROA Y
Higher ROA y-y Y
Cash flow > Earnings Y
Lower Leverage y-y Y
Higher Current Ratio y-y N
Less Shares Outstanding y-y Y
Gross Margin Increase y-y Y
Higher Asset Turnover y-y Y

OCSE:NOVO B Number of Guru Trades

To

OCSE:NOVO B Volume of Guru Trades

To

Gurus Latest Trades with OCSE:NOVO B

No Available Data

OCSE:NOVO B is held by these investors

No Available Data